Posted in | News | Display

Motorola Ventures Invests in Multi-Touch Anywhere Platforms Provider

Motorola, Inc. (NYSE: MOT) today announced that Motorola Ventures, the company's strategic venture capital arm, made an investment in Sensitive Object, a leader in multi-touch anywhere platforms and natural user interface (NUI).

The company was created in October 2003 with an innovative and patent-protected technology capable of "tactilizing" any surface. This unique software technology leverages acoustics to analyze sound waves departing from the point of a touch to precisely and cost-effectively transform any product into a touch device. Sensitive Object's ReverSys(®) software can be deployed in any product benefiting from "touch-based" user interfaces including touch screen and touch control in various markets such as mobile devices.

Sensitive Object's Anywhere MultiTouch(TM) platform extends tactilization to any surface of a device allowing for virtual controls and next generation user-interfaces. As touch and haptics have become standard interaction expectations for personal computing and handheld devices, Sensitive Object demonstrates that acoustic (vs. resistive, capacitive, and optical) tactilization is the state of the art in terms of both performance and cost, and its platform will set a new standard for full 3D device tactilization.

"Natural user interface (NUI) and in particular interacting with a device through touch is an area of rapid development and great excitement," said Reese Schroeder, managing director, Motorola Ventures. "Sensitive Object provides an innovative and unique approach allowing new ways of interaction. We're most excited to be involved in their growth and success."

"We are excited to be working closely with the Motorola team. Motorola is a perfect partner for our disruptive touch solution considering Motorola's innovative and successful history with mobile phones," said Herve Martin, chief executive officer of Sensitive Object.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.